William Blair Investment Management LLC Invests $17.70 Million in Addus HomeCare Corporation $ADUS

William Blair Investment Management LLC acquired a new stake in Addus HomeCare Corporation (NASDAQ:ADUS) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 176,206 shares of the company’s stock, valued at approximately $17,703,000.

Other institutional investors have also recently made changes to their positions in the company. Keebeck Wealth Management purchased a new stake in Addus HomeCare during the 2nd quarter worth approximately $311,000. NFJ Investment Group LLC purchased a new position in Addus HomeCare in the 2nd quarter valued at approximately $29,000. Aurora Investment Counsel purchased a new position in Addus HomeCare in the 2nd quarter valued at approximately $1,821,000. Great Lakes Advisors LLC acquired a new position in shares of Addus HomeCare in the second quarter worth $2,696,000. Finally, Summit Creek Advisors LLC acquired a new position in shares of Addus HomeCare in the second quarter worth $8,552,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Trading Up 0.2%

Shares of NASDAQ:ADUS opened at $120.81 on Friday. Addus HomeCare Corporation has a 52 week low of $87.95 and a 52 week high of $124.43. The company’s 50 day moving average is $109.47 and its two-hundred day moving average is $102.50. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. The company has a market cap of $2.26 billion, a PE ratio of 21.19, a P/E/G ratio of 1.62 and a beta of 0.87.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, beating analysts’ consensus estimates of $1.70 by $0.03. The business had revenue of $377.41 million for the quarter, compared to analyst estimates of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The company’s revenue was up 8.0% on a year-over-year basis. During the same period last year, the business earned $1.49 EPS. Equities analysts predict that Addus HomeCare Corporation will post 6.29 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the sale, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Barclays upped their price objective on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday, July 8th. Citizens Jmp reissued a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research note on Monday, May 18th. Royal Bank Of Canada boosted their target price on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a report on Friday, July 24th. Finally, Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus target price of $130.88.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.